BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kawanaka M, Nishino K, Kawamoto H, Haruma K. Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases. World J Gastroenterol 2021; 27(43): 7497-7508 [PMID: 34887645 DOI: 10.3748/wjg.v27.i43.7497]
URL: https://www.wjgnet.com/1948-5182/full/v27/i43/7497.htm
Number Citing Articles
1
Hong Li, Xiao Lin, Lili Liu, Ling Qin, Yanhong Zheng, Xiaohui Liu, Xinhuan Wei, Shan Liang, Yali Liu, Jing Zhang, Xinyue Chen, Zhenhuan Cao. Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen CarriersFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.864354
2
Chi-Chang Wu. Silicon Nanowires Length and Numbers Dependence on Sensitivity of the Field-Effect Transistor Sensor for Hepatitis B Virus Surface Antigen DetectionBiosensors 2022; 12(2): 115 doi: 10.3390/bios12020115